Dual Multiple Sclerosis Finding May Change Therapy

A cellular signature seen in the blood of multiple sclerosis patients may help determine their likelihood of relapse, potentially influencing which therapy physicians prescribe, a study found.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.